Topical Review Article: Brainstem and Other Malignant Gliomas: II. Possible Mechanisms of Brain Infiltration by Tumor Cells

Abstract

Gliomas that arise in the brain stem and other malignant gliomas constitute approximately 60% of all brain tumors and have eluded effective therapy, in part because they are able to infiltrate the normal brain. Histopathologic studies have confirmed the presence of infiltrating tumor cells very distant from the glioma mass. We review the neuroimaging and pathologic features of glioma-cell infiltration and some of the complex cellular and biochemical determinants of tumor-cell motility and invasiveness. Understanding how glioma cells become motile and invasive is pivotal to therapeutically targeting the machinery that enables gliomas to infiltrate the brain. (J Child Neurol 1993;8:292-305).

Get full access to this article

View all access options for this article.

References

Maria BL , Rehder K. , Eskin TA , et al: Brainstem glioma: I. Pathology, clinical features, and therapy . J Child Neurol 1993; 8:112-128.

deRidder L. , Calliauw L. : Invasion of human brain tumors in vitro: Relationship to clinical evolution . J Neurosurg 1990; 72:589-593.

Burger PC , Heinz ER , Shibata T. , et al: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988;68:698-704.

deRidder LI , Laerum OD , Mrk SJ , et al: Invasiveness of human glioma cell lines in vitro: Relation to tumorigenicity in athymic mice. Acta Neuropathol (Berl) 1987;72:207-213.

Kornblith PL , Walker MD , Cassady JR : Neoplasms of the central nervous system, in De Vita VT , Hellman S , Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, JB Lippincott, 1985, pp 1437-1510.

Packer RJ , Allen JC , Goldwein JL , et al: Hyperfractionated radiotherapy for children with brainstem gliomas: A pilot study using 7,200 cGy. Ann Neurol 1990;27:167-173.

Freeman CR , Krischer J. , Sanford RA , et al: Hyperfractionated radiation therapy in brain stem tumors. Cancer 1991;68: 474-481.

Edwards Msb , Wara WM , Urtasun RC , et al: Hyperfractionated radiation therapy for brainstem gliomas: A phase I-II trial. J Neurosurg 1989;70:691-700.

Mundinger F. , Braus DF , Drauss JK , et al: Long-term outcome of 89 low-grade brain-stem gliomas after interstitial radiation therapy. J Neurosurg 1991;75:740-746.

10.

Russell DS , Rubinstein LJ : Astrocytomas of the brainstem, in Pathology of Tumours of the Nervous System, 5th ed. Baltimore , Williams & Wilkins, 1989, pp 149-152.

11.

Dean BL , Drayer BP , Bird CR , et al: Gliomas: Classification with MR imaging. Radiology 1990;174:411-415.

12.

Greene GM , Hitchon PW , Schelper RL , et al: Diagnostic yield in CT guided stereotactic biopsy of gliomas . J Neurosurg 1989;71:494-497.

13.

Smith RR , Zimmerman RA , Packer RJ , et al: Pediatric brainstem glioma. Post radiation clinical and MR follow up. Neuroradiology 1990;32:265.

14.

Troost D. , Kuiper H. , Valk J. , et al: Gliomatosis cerebri, report of a clinically diagnosed and histologically confirmed case. Clin Neurol Neurosurg 1987 ;89:43-47.

15.

Gregoire N. , Momose T. , Rumeau C. , et al: Gadolinium DTPA in the study of intracranial tumors in the adult. Rev Neurol (Paris) 1990 ;146:133-143.

16.

Kelly PJ , Daumas-Duport C. , Scheithauer BW , et al: Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450-459.

17.

Kelly PJ , Daumas-Duport C. , Kispert DB , et al: Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865-874.

18.

Epstein M. , Zimmerman R. , Rorke L. , et al: Late onset globoid cell leukodystrophy mimicking and infiltrating glioma. Pediatr Radiol 1991;21:131-132.

19.

Quisling R. , Peters K. , Friedman W. , et al: Persistent nidus flow in cerebral arteriovenous malformations after stereotactic radiosurgery: MR imaging assessment . Radiology 1991;180: 785-791.

20.

Schober R. , Mai JK , Volk B. , et al: Gliomatosis cerebri: Bioptical approach and neuropathological verification. Acta Neurochir (Wien) 1991;113:131-137.

21.

Smith RR : Brain stem tumors. Semin Roentgenol 1990;25: 249-262.

22.

Ungersbock K. , Schmidbauer M. , Budka H. , et al: Stereotaxic biopsy of intracranial processes: Validity of histologic diagnosis. Wien Klin Wochenschr 1989;101:376-383.

23.

Bricolo A. , Turazzi S. , Cristofori L. , et al: Direct surgery for brainstem tumours. Acta Neurochir Suppl (Wien) 1991;53: 148-158.

24.

Gorecki J. , Dolan EJ , Tasker RR , et al: Correlation of CT and MR with impedance monitoring and histopathology in stereotactic biopsies. Can J Neurol Sci 1990;17:184-189.

25.

Abernathey CD , Camacho A. , Kelly PJ : Stereotaxic suboccipital transcerebellar biopsy of pontine mass lesions. J Neurosurg 1989;70:195-200.

26.

Ross IB , Robitaille Y. , Villemure JG , et al: Diagnosis and management of gliomatosis cerebri: Recent trends . Surg Neurol 1991;36:431-440.

27.

Scherer HJ : Structural development in gliomas. Am J Cancer 1938;34:333-351.

28.

Scherer HJ : The forms of growth in gliomas and their practical significance. Brain 1940;63:1-35.

29.

Taraboletti G. , Rao CN , Krutzsch HC , et al: Sulfatide-binding domain of the laminin A chain. J Biol Chem 1990;265: 12253-12258.

30.

Woolley DE , Tetlow LC , et al: in Strauli P , et al (eds): New York, Raven Press, 1980, pp 97-134.

31.

Liotta LA , Abe S. , Robey PG , et al: Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc Natl Acad Sci U S A 1979; 76:2268-2272.

32.

Stack S. , Gray RD , Pizzo SV : Modulation of plasminogen activation and type IV collagenase activity by a synthetic peptide derived from the laminin A chain. Biochemistry 1991;30: 2073-2077.

33.

Stetler-Stevenson WG : Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289-303.

34.

Yagel S. , Parhar RS , Jeffrey JJ , et al: Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol 1988;136:455-462.

35.

Gross JL , Behrens DL , Mullins DE , et al: Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res 1988;48:291-296.

36.

Mignatti P. , Robbins E. , Rifkin DB : Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 1986;47:487-498.

37.

Testa JE , Quigley JP : The role of urokinase-type plasminogen activator in aggressive tumor cell behavior. Cancer Metastasis Rev 1990;9:353-367.

38.

Bejarano PA , Noelken ME , Suzuki K. , et al: Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem J 1988;256:413-419.

39.

Patterson PH : On the role of proteases, their inhibitors and the extracellular matrix in promoting neurite outgrowth. J Physiol ( Paris) 1985;80:207-211.

40.

Docherty AJ , Lyons A. , Smith BJ , et al: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity . Nature 1985;318:66-69.

41.

Schultz RM , Silberman S. , Persky B. , et al: Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 1988;48:5539-5545.

42.

Khokha R. , Waterhouse P. , Yagel S. , et al: Antisense RNAinduced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989 ;243:947-950.

43.

Nelson RB , Siman R. : Identification and characterization of calcium-dependent metalloproteases in rat brain. Neurochem Res 1989;53:641-647.

44.

Herron GS , Werb Z. , Dwyer K. , et al: Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 1986;261:2810-2813.

45.

Murphy S. , McCabe N. , Morrow C. , et al: Phorbol ester stimulates proliferation of astrocytes in primary culture. Brain Res 1987;428:133-135.

46.

Mawatari M. , Kohno K. , Mizoguchi H. , et al: Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J Immunol 1989;143:1619-1627.

47.

Marsh L. , Letourneau PC : Growth of neurites without filopodial or lamellipodial activity in the presence of cytochalsin B. J Cell Biol 1984;99:2041-2047.

48.

Bray D. , White JG : Cortical flow in animal cells. Science 1988 ;239:883-888.

49.

Mitchison T. , Kirschner M. : Cytoskeletal dynamics and nerve growth. Neuron 1988;1:761-772.

50.

Smith SJ : Neuronal cytomechanics: The actin-based motility of growth cones. Science 1988;242:708-715.

51.

Bentley D. , Toroian-Raymond A. : Disoriented pathfinding by pioneer neurone growth cones deprived of filopodia by cytochalasin treatment. Nature 1986;323:712-715.

52.

Pollard TD , Cooper JA : Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Annu Rev Biochem 1986;55:987-1035.

53.

Maria BL , Cumming R. , Sukhu L. : Crown of microfilaments in the extending cytoplasmic processes of medulloblastoma glial progenitors. Can J Neurol Sci 1992;19:23-33.

54.

Hynes RO : Integrins: A family of cell surface receptors. Cell 1987;48:549- 554.

55.

Forscher P. , Smith SJ : Actions of cytochalasins on the organization of actin filaments and microtubules in a neuronal growth cone . J Cell Biol 1988;107:1505-1516.

56.

Warrick HM , Spudich JA : Myosin structures and functions in cell motility. Annu Rev Cell Biol 1987;3:379-421.

57.

Yanagida T. , Nakase M. , Nishiyama K. , et al: Direct observation of motion of single F-actin filaments in the presence of myosin. Nature 1984;307:58-60.

58.

Takahashi M. , Kawamoto S. , Yu JH , et al: J Cell Biol 1991;115:333a.

59.

Luckenbill-Edds L. , Kleinman HK : Effect of laminin and cytoskeletal agents on neurite formation by NG108-15 cells. J Neurosci Res 1988;19:219-229.

60.

Eskstein DJ , Shur BD : Laminin induces the stable expression of surface galactosyltransferase on lamellipodia of migrating cells. J Cell Biol 1989;108:2507-2517.

61.

Devoto SH : Neuronal growth cone migration. Experientia 1990;46:916-922.

62.

Letourneau PC , Pech IV , Rogers SL , et al: Growth cone migration across extracellular matrix components depends on integrin, but migration across glioma cells does not. Neurosci Res 1988;21:286-297.

63.

Mason CA , Edmondson JC , Hatten ME : The extending astroglial process: Development of glial cell shape, the growing tip, and interactions with neurons. J Neurosci 1988;8: 3124-3134.

64.

Fridman R. , Giaccone G. , Kanemoto T. , et al: Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci U S A 1990;87:6698-6702.

65.

Engvall E. , Earwicker D. , Haaparanta T. , et al: Distribution and isolation of four laminin variants: Tissue restricted distribution of heterotrimers assembled from five different subunits . Cell Regul 1990;1:731-740.

66.

Sweeney TM , Kibbey MC , Zain M. , et al: Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases. Cancer Metastasis Rev 1991;10: 245-254.

67.

Graf J. , Iwamoto Y. , Sasaki M. , et al: Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis and receptor binding. Cell 1987:48:989-996.

68.

Aumailley M. , Nurcombes V. , Edgar D. , et al: The cellular interactions of laminin fragments: Cell adhesion correlates with two fragment-specific high affinity binding sites. J Biol Chem 1987 ;262:11532-11538.

69.

Kanemoto T. , Reich R. , Royce L. , et al: Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production . Proc Natl Acad Sci U S A 1990;87:2279-2283.

70.

McComb RD , Binger DD : Immunolocalization of monoclonal antibody-defined extracellular matrix antigens in human brain tumors. Neurooncol 1985;3:181-186.

71.

Hagg T. , Muir DF , Engval E. , et al: Laminin-like antigen in rat CNS neurons: Distribution and changes upon brain injury and nerve growth factor treatment. Neuron 1989;3:721-732.

72.

Gladson CL , Cheresh DA : Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 1991;88:1924-1932.

73.

Heino J. , Ignotz RA , Hemler ME , et al: Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem 1989;264:380-388.

74.

Edwards DR , Murphy G. , Reynolds JJ , et al: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.

75.

Hanley MR : Peptide regulatory factors in the nervous system. Lancet 1989;1:1373-1376.

76.

Hanley MR : Proto-oncogenes in the nervous system. Neuron 1988;1:175-182.

77.

Lindsay RM , Harmar AJ : Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337:362-364.

78.

Vlodavsky I. , Korner G. , Ishai-Michaeli R. , et al: Cancer Metastasis Rev 1990;9:203-226.

79.

Ross R. : Platelet-derived growth factor. Lancet 1989 ;1: 1179-1182.

80.

Pringle N. , Collarini EJ , Mosley MJ , et al: PDGF A chain homodimers drive proliferation of bipotential (0-2A) glial progenitor cells in the developing rat optic nerve. EMBO J 1989;8:1049-1056.

81.

Claesson-Welsh L. , Hammacher A. , Westermark B. , et al: Identification and structural analysis of the A type receptor for platelet-derived growth factor. Similarities with the B type receptor. J Biol Chem 1989;264:1742-1747.

82.

Hermansson M. , Nister M. , Betsholtz C. , et al: Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation . Proc Natl Acad Sci U S A 1988;85:7748-7752.

83.

Nister M. , Libermann TA , Betsholtz C. , et al: Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 1988;48:3910-3918.

84.

Laiho M. , Keski-Oja J. : Growth factors in the regulation of peri-cellular proteolysis: A review . Cancer Res 1989;49:2533-2553.

85.

Sainsbury JR , Farndon JR , Sherbet GV , et al: Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet 1985;1:364-366.

86.

Kalofonos HP , Pawlikowska TR , Hemingway A. , et al: Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase . J Nucl Med 1989;30:1636-1645.

87.

Di-Stefano JF , Kirchner M. , Dagenhardt K. , et al: Activation of cancer cell proteases and cytotoxicity by EGF and PDGF growth factors. Am J Med Sci 1990;300:9-15.

88.

Dennis MS , Henzel WJ , Pitti RM , et al: Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors. Proc Natl Acad Sci U S A 1990;87:2471-2475.

89.

Rucinski B. , Niewiarowski S. , Holt JC , et al: Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. Biochim Biophys Acta 1990;1054:257-262.

90.

Wujek JR , Haleem-Smith H. , Yamada Y. , et al: Evidence that the B2 chain of laminin is responsible for the neurite outgrowth-promoting activity of astrocyte extracellular matrix. Brain Res Dev Brain Res 1990;55:237-247.